Comparing a new biopsy needle to the standard one for prostate cancer
Part of Cancer clinical trials.
This study tests a new, specially designed biopsy needle system against the standard needle system used for prostate biopsies. The researchers will compare how well each system collects tissue samples from men who have suspicious MRI findings, to see if the new needle might give better results.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man over 18.
- You have a PSA density of 0.15 or higher (a number your doctor can calculate from your PSA level and prostate size).
- You have a suspicious spot on your prostate that can be seen on an MRI scan (with a PI-RADS score of 3 or higher).
- You have not had any previous treatment for prostate cancer (like surgery, radiation, hormone therapy, or chemotherapy).
- Your cancer has not spread beyond the prostate, and your tumor stage is not T2c, T3, or T4.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares a new prostate biopsy system/needle with the standard biopsy needle during your scheduled prostate biopsy. It looks at how well the procedure collects tissue for diagnosis and how the tissue samples compare.
This study compares two different needle sizes used during a prostate biopsy to see which one finds cancer more accurately and causes fewer side effects. It is for people who have not been diagnosed with prostate cancer before and have a suspicious MRI finding.
This trial is testing whether taking extra biopsy samples from specific areas seen on an MRI can better detect prostate cancer compared to the standard method of taking samples from all over the prostate. It may help men who have a suspicious MRI finding and a higher PSA level.
This study is testing a new approach to prostate biopsy that takes samples from around a suspicious area seen on MRI. It aims to see if this method can better detect prostate cancer compared to standard biopsy.
This study tests a new way to guide prostate biopsies using a special scan (PSMA PET/CT) that highlights suspicious areas. If you need a biopsy because of high PSA and abnormal MRI, this approach might help make the biopsy more accurate.
This trial compares a new micro-ultrasound technique to standard ultrasound during prostate biopsy, using MRI results as a guide. It aims to see if the newer method finds cancer more accurately.
Hear when a new Prostate Cancer Screening trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.